Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05199597Phase 1Completed
Phase 1, randomised, single-blind trial of atropine in myopia, sponsored by The Ohio State University. Primary endpoint: Time to Return to Baseline Comfort. Started May 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05199597.